Globiox's Solution:
We believe it is important to take a deliberate, educated, organized approach to addressing the issues identified in a 483 or Warning Letter. We have proven that Globiox’s project managers and subject matter experts are able to analyze the issues, determine solutions, develop a project plan with tasks, resources and a timeline, and develop a strategy for communicating progress to the FDA. Our team will give you the expertise, confidence, and perhaps culture change, needed to resolve your issues and put you back into compliance with regulations.